Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jun 15;8(6):8740-8.
eCollection 2015.

Meta-analysis on autologous stem cell transplantation in the treatment of limb ischemic

Xiuqin Sun  1 , Jilin Ying  2 , Yunan Wang  3 , Wei Li  4 , Yaojiang Wu  5 , Baoting Yao  3 , Ying Liu  3 , Hongkai Gao  6 , Xiaomei Zhang  7
Affiliations

Meta-analysis on autologous stem cell transplantation in the treatment of limb ischemic

Xiuqin Sun et al. Int J Clin Exp Med. .

Abstract

Aim: Meta-analysis on the effectiveness of the autologous stem cell transplantation in curing limb ischemic.

Method: Consulting papers relate to the autologous stem cell transplantation in curing limb ischemic in PubMed, CNKI, Wan-fang Data and VIP. Based on include and exclude standards, we arrange at least 2 evaluators sifting these papers separately, doing Quality evaluation and information extraction and then cross checking. Negotiate through a third party if any disagreement comes out. Review Manager 4.2 is used in Meta-analysis.

Result: Involved 7 papers, all in English version. Patients involved all diagnosed as critical limb ischemia (CLI). Results show that no adverse reaction occurred during this study. Amputation rate in patients with stem cell group treatment is lower than control group (P < 0.05). And no notable difference in improving ABI (P > 0.05).

Conclusions: Applying autologous stem cell transplantation in curing limb ischemic does not have obviously effectiveness in the improvement of ABI of the limb ischemic patients. But it can dramatically reduce the rate of amputation. So autologous stem cell transplantation is a good and safe choice for patients have no choice but amputation.

Keywords: Stem cell; limb ischemic; meta-analysis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Put these 7 literatures into funnel plot, and shows that the true value of the included studies is the symmetric distribution center, suggesting that difference is less.
Figure 2
Figure 2
Sensitivity analysis shows the various research studies included did not deviate from the true value was found, the weight is too large or too small.
Figure 3
Figure 3
Various studies by Begg’s test shows Pr > |z| = 0.548 no statistical significance was not found published offset.
Figure 4
Figure 4
The reducing amputation rate compared with the control group shows that autologous stem cell transplantation can significantly reduce the amputation rate among patients with limb ischemia, difference between them has statistically significant.
Figure 5
Figure 5
Prompted in improving ABI, compared with autologous stem cell transplantation shows that the treatment group and the control group had no significant improvement in the treatment, the difference between the two groups has no statistically significance.
See this image and copyright information in PMC

References

    1. Sun L, Wu L, Qiao Z, Yu J, Li L, Li S, Liu Q, Hu Y, Xu N, Huang P. Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia. Cytotherapy. 2014;16:1110–1116. - PubMed
    1. Minar E. Critical limb ischaemia. Hamostaseologie. 2009;29:102–109. - PubMed
    1. Miyahara T, Shigematsu K, Nishiyama A, Hashimoto T, Hoshina K, Watanabe T. Long-term results of combined aortoiliac and infrainguinal arterial reconstruction for the treatment of critical limb ischemia. Ann Vasc Dis. 2015;8:14–20. - PMC - PubMed
    1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG, Bell K, Caporusso J, Durand-Zaleski I, Komori K, Lammer J, Liapis C, Novo S, Razavi M, Robbs J, Schaper N, Shigematsu H, Sapoval M, White C, White J, Clement D, Creager M, Jaff M, Mohler E 3rd, Rutherford RB, Sheehan P, Sillesen H, Rosenfield K. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) Eur J Vasc Endovasc Surg. 2007;33(Suppl 1):S1–75. - PubMed
    1. Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001;344:1608–1621. - PubMed